Innovation drives progress, and in the healthcare sector, that often means saving lives by finding new ways to diagnose or treat potentially deadly illnesses. Those companies at the forefront of innovation can help improve the lives of thousands of people while providing outsized returns to investors over the long run.
There are many such corporations to consider on the market, but let's examine two: Guardant Health (NASDAQ: GH) and Sarepta Therapeutics (NASDAQ: SRPT) . Read on to find out why both companies are worth holding onto for a while.
Progress in cancer research is always important as cancer is a leading cause of death worldwide. Guardant Health focuses on developing liquid biopsies -- tests that help detect signs of cancer from blood samples. This cancer testing method is often preferred to tissue biopsies since the former are non-invasive and faster.
For further details see:
2 Top Healthcare Stocks to Buy for the Long Haul